Author

M. Amano

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3 Cell Biology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 6 Organism:human· 4 Research Focus:drug response / drug discovery· 3 Research Focus:host-pathogen & immune response· 3 Research Focus:cell signaling & trafficking· 2 Research Focus:cancer & tumor microenvironment· 1 Organism:mouse· 1 Assay:multiome· 1

Frequent Co-Authors

A. Yoshida· 3 shared M. Fujioka· 3 shared S. Kashiwagi· 3 shared Y. Fujioka· 3 shared Y. Ohba· 3 shared A. O. Satoh· 2 shared H. Nakata· 2 shared H. Sasajima· 2 shared

Activity by Year

2019-2022 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCell Biology

A. Yoshida

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

Controllable self-replicating RNA vaccine delivered intradermally elicits predominantly cellular immunity

T. Amano, H. Yu, M. Amano, E. Leyder, M. Badiola, P. Ray, J. Kim, A. C. Ko, A. Achour, N.-p. Weng, E. Kochba, Y. Levin, M. S. H. Ko

This paper develops a temperature-controlled self-replicating RNA vaccine that elicits cellular immunity and can be used as a pan-coronavirus booster.

bioRxiv · Sep 5, 2022Immunology

A method for the generation of pseudotyped virus particles bearing SARS coronavirus spike protein in high yields

Y. Fujioka, S. Kashiwagi, A. Yoshida, A. O. Satoh, M. Fujioka, M. Amano, Y. Yamauchi, Y. Ohba

This paper describes an improved method to produce SARS-CoV and SARS-CoV-2 Spike protein pseudotyped VSV particles for coronavirus entry studies and antiviral development.

bioRxiv · Jul 30, 2021 · PreprintMicrobiology

A small molecule, ACAi-028, with anti-HIV-1 activity targets a novel hydrophobic pocket on HIV-1 capsid

T. Nakamura, T. chia, M. Amano, N. Takamune, M. Matsuoka, H. Nakata

ACAi-028 inhibits HIV-1 replication by targeting a novel hydrophobic pocket on the capsid N-terminal domain, showing potential as a new anti-HIV-1 inhibitor.

bioRxiv · May 18, 2021Microbiology

Interaction Between Phosphoinositide 3-Kinase and the VDAC2 Channel Tethers Endosomes to Mitochondria and Promotes Endosome Maturation

A. O. Satoh, Y. Fujioka, S. Kashiwagi, A. Yoshida, M. Fujioka, H. Sasajima, A. Nanbo, M. Amano, Y. Ohba

This study identifies VDAC2 as a mitochondrial protein that binds PI3K, tethers endosomes to mitochondria, and promotes endosome maturation through both structural and pore functions.

bioRxiv · Jan 18, 2021 · PreprintCell Biology

A unique conformational escape reaction of HIV-1 against an allosteric integrase inhibitor

T. Nakamura, T. Nakamura, M. Amano, T. Miyakawa, Y. Yamagata, M. Matsuoka, H. Nakata

The paper identifies a novel conformational escape mechanism of HIV-1 integrase against NCINIs through under-multimerization of the IN protein.

bioRxiv · Nov 9, 2019Microbiology

Localization of BCR-ABL to stress granules contributes to its oncogenic function

S. Kashiwagi, Y. Fujioka, T. Kondo, A. O. Satho, A. Yoshida, M. Fujioka, H. Sasajima, M. Amano, T. Teshima, Y. Ohba

This study shows BCR-ABL localizes to stress granules, and this localization contributes to its oncogenic function in CML.

bioRxiv · Oct 20, 2019Cell Biology